i2o Therapeutics

i2o Therapeutics is a biotechnology company dedicated to developing safe and effective oral formulations traditionally limited to injectables. The platform utilizes innovative ionic liquid technology, leveraging the advantage of protecting drug payloads while transiently enhancing the permeability of epithelial layers during oral administration. i2o focuses on creating the next generation of oral peptide and protein-based therapies.